Alps Group Inc
For the period ended Feb 4, 2026. Filed Feb 5, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Feb 4, 2026 · Filed Feb 5, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · 28. Operating segments
28. Operating segments
The Group is organised into business units based on its products and services, and has three reportable operating segments as follow:
| Medical and Wellness | Non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research and COVID-19 testing |
|---|---|
| Life Science | Whole genome sequencing and pharmacogenomics |
| Others | Investment holding and provision for management services |
Management monitors the operating results of its business units separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on operating profit or loss which, in certain respects as explained in the table below, is measured differently from operating profit or loss in the consolidated statement of profit or loss and other comprehensive income. Group financing (including finance costs) and income taxes are managed on a group basis and are not allocated to operating segments
The following is an analysis of the Group’s revenue and results by the operating segments.
| Medical and Wellness | Life Science | Others | Eliminations | Consolidated | |
|---|---|---|---|---|---|
| USD | USD | USD | USD | USD | |
| The Group | |||||
| Revenue | |||||
| External sales | 2,041,899 | 9,041 | 148,905 | 2,199,845 | |
| Inter-segment sales | 107,905 | 355,206 | 41,691 | (504,802) | - |
| Total revenue | 2,149,804 | 364,247 | 190,596 | (504,802) | 2,199,845 |
| Result | |||||
| Loss from operations | (50,646) | (509,215) | (679,546) | (3,644) | (1,243,051) |
| Finance costs | (14,208) | (12,294) | (5,765) | 3,644 | (28,623) |
| Profit/(Loss) before tax | (64,854) | (521,509) | (685,311) | - | (1,271,674) |
| Income tax expense | (67,519) | - | - | (1,621) | (69,140) |
| Loss for the financial year | (132,373) | (521,509) | (685,311) | - | (1,340,814) |
| Segment assets | 2,622,443 | 3,905,767 | 14,273,898 | (8,216,698) | 12,585,410 |
| Segment liabilities | 3,732,701 | 8,079,589 | 6,445,288 | (8,036,502) | 10,221,076 |
| Other information | |||||
| Amortisation of intangible assets | - | - | 163,093 | - | 163,093 |
| Amortisation of right-of-use assets | 199,618 | 121,530 | 178,996 | - | 500,144 |
| Additional of property, plant and equipment | 35,675 | 41,989 | 6,108 | - | 83,772 |
| Depreciation of property, plant and equipment | 58,580 | 386,024 | 20,683 | - | 465,287 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.